Seo S, Ju S, Chung H, Lee D, Park S
Empagliflozin is also PBS listed for HFrEF, independent of diabetes status, but is not currently TGA approved for CKD
Other neurological symptoms such as peripheral neuropathy, paresthesias, or allodynia have not been consistently reported as adverse effects attributable to semaglutide in controlled trials
Many street drugs are laced with other dangerous drugs that can lead to serious health complications like overdose
ApoB, apolipoprotein B
In a prospective cohort study of 36 patients with albuminuria who were initiated on sitagliptin 50 mg daily, patients experienced a significant change in both systolic and diastolic BP that was apparent after 6 months (baseline systolic BP 140 +/ 18 mmHg dropped to 129 +/ 17 mmHg and baseline diastolic BP 77 +/ 10 mmHg fell to 73 +/ 7 mmHg